rs143278116
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_001040108.2(MLH3):āc.2449A>Gā(p.Ser817Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000416 in 1,614,034 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ā ).
Frequency
Consequence
NM_001040108.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MLH3 | NM_001040108.2 | c.2449A>G | p.Ser817Gly | missense_variant | 2/13 | ENST00000355774.7 | NP_001035197.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MLH3 | ENST00000355774.7 | c.2449A>G | p.Ser817Gly | missense_variant | 2/13 | 5 | NM_001040108.2 | ENSP00000348020 | P1 | |
MLH3 | ENST00000380968.6 | c.2449A>G | p.Ser817Gly | missense_variant | 2/12 | 1 | ENSP00000370355 | |||
MLH3 | ENST00000556257.5 | c.2449A>G | p.Ser817Gly | missense_variant | 2/7 | 5 | ENSP00000451540 | |||
MLH3 | ENST00000555671.1 | upstream_gene_variant | 5 |
Frequencies
GnomAD3 genomes AF: 0.000315 AC: 48AN: 152258Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000358 AC: 90AN: 251392Hom.: 0 AF XY: 0.000368 AC XY: 50AN XY: 135870
GnomAD4 exome AF: 0.000427 AC: 624AN: 1461776Hom.: 0 Cov.: 35 AF XY: 0.000415 AC XY: 302AN XY: 727184
GnomAD4 genome AF: 0.000315 AC: 48AN: 152258Hom.: 0 Cov.: 33 AF XY: 0.000363 AC XY: 27AN XY: 74382
ClinVar
Submissions by phenotype
not specified Benign:2
Likely benign, criteria provided, single submitter | clinical testing | Center for Genomic Medicine, Rigshospitalet, Copenhagen University Hospital | Aug 15, 2023 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 21, 2020 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Colorectal cancer, hereditary nonpolyposis, type 7 Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 11, 2024 | - - |
Colorectal cancer, non-polyposis Benign:1
Likely benign, no assertion criteria provided | research | CSER _CC_NCGL, University of Washington | Jun 01, 2014 | - - |
not provided Benign:1
Likely benign, no assertion criteria provided | clinical testing | Department of Pathology and Laboratory Medicine, Sinai Health System | - | The MLH3 p.Ser817Gly variant was identified in 1 of 714 proband chromosomes (frequency: 0.0014) from an individual suspected of hereditary nonpolyposis colorectal cancer who also had a variant in MSH6 (IVS9+43 ins10 bp); this variant was not found in 188 Dutch control individuals (Wu_2001_PMID:11586295). The variant was identified in dbSNP (ID: rs143278116) and ClinVar (classified as likely benign by Invitae and CSER _CC_NCGL University of Washington for Non-polyposis colorectal cancer). The variant was identified in control databases in 96 of 268264 chromosomes at a frequency of 0.0003579 (Genome Aggregation Database March 6, 2019, v2.1.1, non-cancer). The variant was observed in the following populations: European (non-Finnish) in 82 of 118116 chromosomes (freq: 0.000694), Other in 4 of 6704 chromosomes (freq: 0.000597), Latino in 8 of 35108 chromosomes (freq: 0.000228), African in 1 of 23616 chromosomes (freq: 0.000042) and European (Finnish) in 1 of 25088 chromosomes (freq: 0.00004), but was not observed in the Ashkenazi Jewish, East Asian, or South Asian populations. The p.Ser817 residue is not conserved in mammals and computational analyses (PolyPhen-2, SIFT, AlignGVGD, BLOSUM, MutationTaster) do not suggest a high likelihood of impact to the protein; however, this information is not predictive enough to rule out pathogenicity. The variant occurs outside of the splicing consensus sequence and 1 of 4 in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer) predict a greater than 10% difference in splicing; this is not very predictive of pathogenicity. Functional studies did not demonstrate a detrimental effect from this variant compared to wildtype (Korhonen_2008_PMID:18521850; Ou_2009_PMID:19156873). In summary, based on the above information the clinical significance of this variant cannot be determined with certainty at this time although we would lean towards a more benign role for this variant. This variant is classified as likely benign. - |
MLH3-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jan 21, 2022 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at